The specific immunogen used to produce this antibody is proprietary information.

IRF3 (Phospho Ser386) Monoclonal Antibody detects endogenous levels of IRF3 protein only when phosphorylated at S386.The name of modified sites may be influenced by many factors, such as species (the modified site was not originally found in human samples) and the change of protein sequence (the previous protein sequence is incomplete, and the protein sequence may be prolonged with the development of protein sequencing technology). When naming, we will use the "numbers" in historical reference to keep the sites consistent with the reports. The antibody binds to the following modification sequence (lowercase letters are modification sites):ASsLE

IRF3

Interferon regulatory factor 3

IRF3 ;
Interferon regulatory factor 3 ;
IRF-3

This gene encodes a member of the interferon regulatory transcription factor (IRF) family. The encoded protein is found in an inactive cytoplasmic form that upon serine/threonine phosphorylation forms a complex with CREBBP. This complex translocates to the nucleus and activates the transcription of interferons alpha and beta , as well as other interferon-induced genes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq , Nov 2011] ,

Function:Mediates interferon-stimulated response element (ISRE) promoter activation. Functions as a molecular switch for antiviral activity. DsRNA generated during the course of an viral infection leads to IRF3 phosphorylation on the C-terminal serine/threonine cluster. This induces a conformational change , leading to its dimerization , nuclear localization and association with CREB binding protein (CREBBP) to form dsRNA-activated factor 1 (DRAF1) , a complex which activates the transcription of genes under the control of ISRE. The complex binds to the IE and PRDIII regions on the IFN-alpha and IFN-beta promoters respectively. IRF-3 does not have any transcription activation domains. ,PTM:Constitutively phosphorylated on many serines residues. C-terminal serine/threonine cluster is phosphorylated in response of induction by IKBKE and TBK1. Ser-385 and Ser-386 may be specifically phosphorylated in response to induction. An alternate model propose that the five serine/threonine residues between 396 and 405 are phosphorylated in response to a viral infection. Phosphorylation , and subsequent activation of IRF3 is inhibited by vaccinia virus protein E3. ,similarity:Belongs to the IRF family. ,similarity:Contains 1 tryptophan pentad repeat DNA-binding domain. ,subcellular location:Shuttles between cytoplasmic and nuclear compartments , with export being the prevailing effect. When activated , IRF3 interaction with CREBBP prevents its export to the cytoplasm. ,subunit:Homodimer; phosphorylation-induced. Interacts with CREBBP. May interact with MAVS. Interacts with IKBKE and TBK1. Interacts with TICAM1 and TICAM2. Interacts with rotavirus A NSP1 (via C-terminus) ; this interaction leads to the proteasome-dependent degradation of IRF3. ,tissue specificity:Expressed constitutively in a variety of tissues. ,

Cytoplasm . Nucleus . Mitochondrion . Shuttles between cytoplasmic and nuclear compartments , with export being the prevailing effect (PubMed:10805757) . When activated , IRF3 interaction with CREBBP prevents its export to the cytoplasm (PubMed:10805757) . Recruited to mitochondria via TOMM70:HSP90AA1 upon Sendai virus infection (PubMed:25609812) . .

>>Toll-like receptor signaling pathway ;
>>NOD-like receptor signaling pathway ;
>>RIG-I-like receptor signaling pathway ;
>>Cytosolic DNA-sensing pathway ;
>>Alcoholic liver disease ;
>>Shigellosis ;
>>Pertussis ;
>>Yersinia infection ;
>>Hepatitis C ;
>>Hepatitis B ;
>>Measles ;
>>Human cytomegalovirus infection ;
>>Influenza A ;
>>Human papillomavirus infection ;
>>Kaposi sarcoma-associated herpesvirus infection ;
>>Herpes simplex virus 1 infection ;
>>Epstein-Barr virus infection ;
>>Human immunodeficiency virus 1 infection ;
>>Coronavirus disease - COVID-19 ;
>>Viral carcinogenesis ;
>>Lipid and atherosclerosis